The acute effects of aerobic exercise on sleep in patients with depression: study protocol for a randomized controlled trial

Gavin Brupbacher, Doris Straus, Hildburg Porschke, Thea Zander-Schellenberg, Markus Gerber, Roland von Känel, Arno Schmidt-Trucksäss, Gavin Brupbacher, Doris Straus, Hildburg Porschke, Thea Zander-Schellenberg, Markus Gerber, Roland von Känel, Arno Schmidt-Trucksäss

Abstract

Background: Unipolar depression is one of the most important mental disorders. Insomnia is a symptom of cardinal importance in depression. It increases the risk to develop depression, negatively affects disease trajectory, is the most common symptom after remission, increases the risk of relapse, and is associated with higher suicide rates. Existing therapies for insomnia in depression have limitations. Further adjuvant therapies are therefore needed. Acute aerobic exercise has been shown to have beneficial effects on sleep in healthy individuals and patients with insomnia. We therefore hypothesize that a single session of aerobic exercise has a positive impact on sleep in patients with unipolar depression. This trial aims to investigate the effects of a single bout of aerobic exercise on the subsequent night's sleep in patients with depression.

Methods/design: This is a two-arm parallel group, randomized, outcome assessor blinded, controlled, superiority trial. Patients between 18 and 65 years of age with a primary diagnosis of unipolar depression (without a psychotic episode) are included. Exclusion criteria are regular use of hypnotic agents, opioids, and certain beta-blockers, as well as the presence of factors precluding exercise, history of epilepsy, restless legs syndrome, moderate obstructive sleep apnea, and a BMI > 40. The intervention is a single bout of aerobic exercise, performed for 30 min on a bicycle ergometer at 80% individual anaerobic threshold. The control group sits and reads for 30 min. The primary outcome is sleep efficiency measured by polysomnography. Secondary outcomes include further polysomnographic variables, subjective pre-sleep arousal, nocturnal cardiovascular autonomic modulation, subjective sleep quality, daytime sleepiness, and adverse events. According to the sample size calculation, a total of 92 patients will be randomized using minimization.

Discussion: This trial will add new information to the body of knowledge concerning the treatment of insomnia in patients with depression. Thereby, the results will inform decision makers on the utility of acute aerobic exercise.

Trial registration: Clinicaltrials.gov, NCT03673397 . Protocol version 1 registered on 17 September 2018.

Keywords: Blood pressure; Depression; Exercise; Heart rate variability; Polysomnography; Protocol; Randomized controlled trial; Sleep.

Conflict of interest statement

Gavin Brupbacher is funded through an industry sponsored PhD, provided by OBERWAID AG, St. Gallen, Switzerland. Dr. Doris Straus and Dr. Hildburg Porschke are employed by OBERWAID AG. Arno Schmidt-Trucksäss and Roland von Känel are on the scientific advisory board of the Oberwaid AG. All other authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Trial design
Fig. 2
Fig. 2
Participant timeline - Spirit figure

References

    1. Steel Z, Marnane C, Iranpour C, Chey T, Jackson JW, Patel V, et al. The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013. Int J Epidemiol. 2014;43:476–493. doi: 10.1093/ije/dyu038.
    1. Kessler RC, Aguilar-Gaxiola S, Alonso J, Chatterji S, Lee S, Ormel J, et al. The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys. Epidemiol Psichiatr Soc. 2009;18:23–33. doi: 10.1017/S1121189X00001421.
    1. Goodell S, Druss BG, Walker ER. Mental disorders and medical comorbidity. Princeton: Robert Wood Johnson Foundation; 2011.
    1. Gan Y, Gong Y, Tong X, Sun H, Cong Y, Dong X, et al. Depression and the risk of coronary heart disease: a meta-analysis of prospective cohort studies. BMC Psychiatry. 2014;14. 10.1186/s12888-014-0371-z.
    1. Vancampfort D, Rosenbaum S, Schuch F, Ward PB, Richards J, Mugisha J, et al. Cardiorespiratory fitness in severe mental illness: a systematic review and meta-analysis. Sports Med. 2017;47:343–352. doi: 10.1007/s40279-016-0574-1.
    1. Kodama S, Saito K, Tanaka S, Maki M, Yachi Y, Asumi M, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA. 2009;301:2024–2035. doi: 10.1001/jama.2009.681.
    1. National Institute for Health and Clinical Excellence . Depression in adults: recognition and management. 2016.
    1. Holsboer-Trachsler E, Hättenschwiler J, Beck J, Brand S, Hemmeter U, Keck ME, et al. Die somatische Behandlung der unipolaren depressiven Störungen. Swiss Med Forum. 2010;10:802–809.
    1. Cuijpers P, Sijbrandij M, Koole SL, Andersson G, Beekman AT, Reynolds CF. Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis. World Psychiatry. 2014;13:56–67. doi: 10.1002/wps.20089.
    1. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905–1917. doi: 10.1176/ajp.2006.163.11.1905.
    1. Omvik S, Pallesen S, Bjorvatn B, Sivertsen B, Havik OE, Nordhus IH. Patient characteristics and predictors of sleep medication use. Int Clin Psychopharmacol. 2010;25:91–100. doi: 10.1097/YIC.0b013e328334e5e6.
    1. Cheung JMY, Bartlett DJ, Armour CL, Saini B, Laba T-L. Patient preferences for managing insomnia: a discrete choice experiment. The Patient. 2018;11:503–514. doi: 10.1007/s40271-018-0303-y.
    1. McHugh RK, Whitton SW, Peckham AD, Welge JA, Otto MW. Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review. J Clin Psychiatry. 2013;74:595–602. doi: 10.4088/JCP.12r07757.
    1. Edinger JD, Bonnet MH, Bootzin RR, Doghramji K, Dorsey CM, Espie CA, et al. Derivation of research diagnostic criteria for insomnia: report of an American Academy of Sleep Medicine Work Group. Sleep. 2004;27:1567–1596. doi: 10.1093/sleep/27.8.1567.
    1. Baglioni C, Spiegelhalder K, Lombardo C, Riemann D. Sleep and emotions: a focus on insomnia. Sleep Med Rev. 2010;14:227–238. doi: 10.1016/j.smrv.2009.10.007.
    1. Stepanski EJ, Rybarczyk B. Emerging research on the treatment and etiology of secondary or comorbid insomnia. Sleep Med Rev. 2006;10:7–18. doi: 10.1016/j.smrv.2005.08.002.
    1. Medalie L, Cifu AS. Management of Chronic Insomnia Disorder in Adults. JAMA. 2017;317:762–763. doi: 10.1001/jama.2016.19004.
    1. Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008;4:487–504.
    1. Wu JQ, Appleman ER, Salazar RD, Ong JC. Cognitive behavioral therapy for insomnia comorbid with psychiatric and medical conditions: a meta-analysis. JAMA Intern Med. 2015;175:1461–1472. doi: 10.1001/jamainternmed.2015.3006.
    1. Buscemi N, Vandermeer B, Friesen C, Bialy L, Tubman M, Ospina M, et al. The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med. 2007;22:1335–1350. doi: 10.1007/s11606-007-0251-z.
    1. Huedo-Medina TB, Kirsch I, Middlemass J, Klonizakis M, Siriwardena AN. Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration. BMJ. 2012;345:e8343. doi: 10.1136/bmj.e8343.
    1. Kurko TAT, Saastamoinen LK, Tähkäpää S, Tuulio-Henriksson A, Taiminen T, Tiihonen J, et al. Long-term use of benzodiazepines: Definitions, prevalence and usage patterns - a systematic review of register-based studies. Eur Psychiatry. 2015;30:1037–1047. doi: 10.1016/j.eurpsy.2015.09.003.
    1. Sakshaug S, Handal M, Hjellvik V, Berg C, Ripel Å, Gustavsen I, et al. Long-term use of Z-hypnotics and co-medication with benzodiazepines and opioids. Basic Clin Pharmacol Toxicol. 2017;120:292–298. doi: 10.1111/bcpt.12684.
    1. Pillai V, Cheng P, Kalmbach DA, Roehrs T, Roth T, Drake CL. Prevalence and predictors of prescription sleep aid use among individuals with DSM-5 insomnia: the role of hyperarousal. Sleep. 2016;39:825–832. doi: 10.5665/sleep.5636.
    1. Pillai V, Roth T, Roehrs T, Moss K, Peterson EL, Drake CL. Effectiveness of benzodiazepine receptor agonists in the treatment of insomnia: an examination of response and remission rates. Sleep. 2017;40.
    1. Gunja N. In the Zzz Zone: The effects of Z-drugs on human performance and driving. J Med Toxicol. 2013;9:163–171. doi: 10.1007/s13181-013-0294-y.
    1. Kripke DF. Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit. F1000Research. 2016;5:918. doi: 10.12688/f1000research.8729.1.
    1. Lai M-M, Lin C-C, Lin C-C, Liu C-S, Li T-C, Kao C-H. Long-term use of zolpidem increases the risk of major injury: a population-based cohort study. Mayo Clin Proc. 2014;89:589–594. doi: 10.1016/j.mayocp.2014.01.021.
    1. Morin CM, Gaulier B, Barry T, Kowatch RA. Patients’ acceptance of psychological and pharmacological therapies for insomnia. Sleep. 1992;15:302–305. doi: 10.1093/sleep/15.4.302.
    1. Vincent N, Lionberg C. Treatment preference and patient satisfaction in chronic insomnia. Sleep. 2001;24:411–417. doi: 10.1093/sleep/24.4.411.
    1. van MJG, Hoogendijk WJG, Vogelzangs N, van DR, Penninx BWJH. Insomnia and sleep duration in a large cohort of patients with major depressive disorder and anxiety disorders. J Clin Psychiatry. 2010;71:239–246. doi: 10.4088/JCP.09m05218gry.
    1. Spiegelhalder K, Regen W, Nanovska S, Baglioni C, Riemann D. Comorbid sleep disorders in neuropsychiatric disorders across the life cycle. Curr Psychiatry Rep. 2013;15:364. doi: 10.1007/s11920-013-0364-5.
    1. Li L, Wu C, Gan Y, Qu X, Lu Z. Insomnia and the risk of depression: a meta-analysis of prospective cohort studies. BMC Psychiatry. 2016;16:375. doi: 10.1186/s12888-016-1075-3.
    1. Alvaro PK, Roberts RM, Harris JK. A systematic review assessing bidirectionality between sleep disturbances, anxiety, and depression. Sleep. 2013;36:1059–1068. doi: 10.5665/sleep.2810.
    1. Jansson-Fröjmark M, Lindblom K. A bidirectional relationship between anxiety and depression, and insomnia? A prospective study in the general population. J Psychosom Res. 2008;64:443–449. doi: 10.1016/j.jpsychores.2007.10.016.
    1. Sivertsen B, Salo P, Mykletun A, Hysing M, Pallesen S, Krokstad S, et al. The bidirectional association between depression and insomnia: the HUNT study. Psychosom Med. 2012;74:758–765. doi: 10.1097/PSY.0b013e3182648619.
    1. Franzen PL, Buysse DJ. Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications. Dialogues Clin Neurosci. 2008;10:473–481.
    1. Carney CE, Segal ZV, Edinger JD, Krystal AD. A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder. J Clin Psychiatry. 2007;68:254–260. doi: 10.4088/JCP.v68n0211.
    1. Nierenberg AA, Husain MM, Trivedi MH, Fava M, Warden D, Wisniewski SR, et al. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. Psychol Med. 2010;40:41–50. doi: 10.1017/S0033291709006011.
    1. Krystal AD. Psychiatric disorders and sleep. Neurol Clin. 2012;30:1389–1413. doi: 10.1016/j.ncl.2012.08.018.
    1. Sakurai H, Suzuki T, Yoshimura K, Mimura M, Uchida H. Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR*D data. Psychopharmacology. 2017;234:2453–2461. doi: 10.1007/s00213-017-4634-5.
    1. Bernert RA, Kim JS, Iwata NG, Perlis ML. Sleep disturbances as an evidence-based suicide risk factor. Curr Psychiatry Rep. 2015;17:554. doi: 10.1007/s11920-015-0554-4.
    1. Winsper C, Tang NKY. Linkages between insomnia and suicidality: prospective associations, high-risk subgroups and possible psychological mechanisms. Int Rev Psychiatry Abingdon Engl. 2014;26:189–204. doi: 10.3109/09540261.2014.881330.
    1. He Q, Zhang P, Li G, Dai H, Shi J. The association between insomnia symptoms and risk of cardio-cerebral vascular events: A meta-analysis of prospective cohort studies. Eur J Prev Cardiol. 2017;24:1071–1082. doi: 10.1177/2047487317702043.
    1. Kessler RC, Berglund PA, Coulouvrat C, Hajak G, Roth T, Shahly V, et al. Insomnia and the performance of US workers: results from the america insomnia survey. Sleep. 2011;34:1161–1171. doi: 10.5665/SLEEP.1230.
    1. Espie CA, Pawlecki B, Waterfield D, Fitton K, Radocchia M, Luik AI. Insomnia symptoms and their association with workplace productivity: cross-sectional and pre-post intervention analyses from a large multinational manufacturing company. Sleep Health. 2018;4:307–312. doi: 10.1016/j.sleh.2018.03.003.
    1. Reynolds AC, Appleton SL, Gill TK, Taylor AW, McEvoy RD, Ferguson SA, et al. Sickness absenteeism is associated with sleep problems independent of sleep disorders: results of the 2016 Sleep Health Foundation national survey. Sleep Health. 2017;3:357–361. doi: 10.1016/j.sleh.2017.06.003.
    1. Kanerva N, Pietiläinen O, Lallukka T, Rahkonen O, Lahti J. Unhealthy lifestyle and sleep problems as risk factors for increased direct employers’ cost of short-term sickness absence. Scand J Work Environ Health. 2018;44(2):192-201.
    1. Uehli K, Mehta AJ, Miedinger D, Hug K, Schindler C, Holsboer-Trachsler E, et al. Sleep problems and work injuries: A systematic review and meta-analysis. Sleep Med Rev. 2014;18:61–73. doi: 10.1016/j.smrv.2013.01.004.
    1. Dong Liming, Agnew Jacqueline, Mojtabai Ramin, Surkan Pamela J, Spira Adam P. Insomnia as a predictor of job exit among middle-aged and older adults: results from the Health and Retirement Study. Journal of Epidemiology and Community Health. 2017;71(8):750–757. doi: 10.1136/jech-2016-208630.
    1. Paunio T, Korhonen T, Hublin C, Partinen M, Koskenvuo K, Koskenvuo M, et al. Poor sleep predicts symptoms of depression and disability retirement due to depression. J Affect Disord. 2015;172:381–389. doi: 10.1016/j.jad.2014.10.002.
    1. NIH State-of-the-Science Conference Statement on manifestations and management of chronic insomnia in adults. NIH Consens State Sci Statements. 2005;22:1–30.
    1. Lang C, Kalak N, Brand S, Holsboer-Trachsler E, Pühse U, Gerber M. The relationship between physical activity and sleep from mid adolescence to early adulthood. A systematic review of methodological approaches and meta-analysis. Sleep Med Rev. 2015;28:28–41.
    1. Kredlow MA, Capozzoli MC, Hearon BA, Calkins AW, Otto MW. The effects of physical activity on sleep: a meta-analytic review. J Behav Med. 2015;38:427–449. doi: 10.1007/s10865-015-9617-6.
    1. Yang P-Y, Ho K-H, Chen H-C, Chien M-Y. Exercise training improves sleep quality in middle-aged and older adults with sleep problems: a systematic review. J Physiother. 2012;58:157–163. doi: 10.1016/S1836-9553(12)70106-6.
    1. Passos GS, Poyares DLR, Santana MG, Tufik S, de Mello MT. Is exercise an alternative treatment for chronic insomnia? Clinics. 2012;67:653–660. doi: 10.6061/clinics/2012(06)17.
    1. Cooney GM, Dwan K, Greig CA, Lawlor DA, Rimer J, Waugh FR, et al. Exercise for depression. Cochrane Database Syst Rev. 2013;12(9):CD004366.
    1. Stubbs B, Rosenbaum S, Vancampfort D, Ward PB, Schuch FB. Exercise improves cardiorespiratory fitness in people with depression: A meta-analysis of randomized control trials. J Affect Disord. 2016;190:249–253. doi: 10.1016/j.jad.2015.10.010.
    1. American Sleep Association. Sleep hygiene tips. 2017. . Accessed 28 Apr 2017.
    1. Gold PW. The organization of the stress system and its dysregulation in depressive illness. Mol Psychiatry. 2015;20:32–47. doi: 10.1038/mp.2014.163.
    1. Myllymäki T, Kyröläinen H, Savolainen K, Hokka L, Jakonen R, Juuti T, et al. Effects of vigorous late-night exercise on sleep quality and cardiac autonomic activity. J Sleep Res. 2011;20(1 Pt 2):146–153. doi: 10.1111/j.1365-2869.2010.00874.x.
    1. Myllymäki T, Rusko H, Syväoja H, Juuti T, Kinnunen M-L, Kyröläinen H. Effects of exercise intensity and duration on nocturnal heart rate variability and sleep quality. Eur J Appl Physiol. 2012;112:801–809. doi: 10.1007/s00421-011-2034-9.
    1. Passos GS, Poyares D, Santana MG, Garbuio SA, Tufik S, Mello MT. Effect of acute physical exercise on patients with chronic primary insomnia. J Clin Sleep Med. 2010;6:270–275.
    1. Banno M, Harada Y, Taniguchi M, Tobita R, Tsujimoto H, Tsujimoto Y, et al. Exercise can improve sleep quality: a systematic review and meta-analysis. PeerJ. 2018;6:e5172. doi: 10.7717/peerj.5172.
    1. Baron KG, Reid KJ, Zee PC. Exercise to improve sleep in insomnia: exploration of the bidirectional effects. J Clin Sleep Med. 2013;9:819–824.
    1. Miura A, Myouken S, Yamada M, Fujihara C, Miura K, Kashima H, et al. Effects of aerobic exercise in early evening on the following nocturnal sleep and its haemodynamic response. Res Sports Med Print. 2016;24:16–29. doi: 10.1080/15438627.2015.1076415.
    1. Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200–207. doi: 10.7326/0003-4819-158-3-201302050-00583.
    1. Klerman EB, Wang W, Duffy JF, Dijk D-J, Czeisler CA, Kronauer RE. Survival analysis indicates that age-related decline in sleep continuity occurs exclusively during NREM sleep. Neurobiol Aging. 2013;34:309–318. doi: 10.1016/j.neurobiolaging.2012.05.018.
    1. American College of Sports Medicine . ACSM’s Guidelines for Exercise Testing and Prescription. 8. Philadelphia: LWW; 2009.
    1. Stoschitzky K, Sakotnik A, Lercher P, Zweiker R, Maier R, Liebmann P, et al. Influence of beta-blockers on melatonin release. Eur J Clin Pharmacol. 1999;55:111–115. doi: 10.1007/s002280050604.
    1. Stoschitzky K, Stoschitzky G, Brussee H, Bonelli C, Dobnig H. Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol. Cardiology. 2006;106:199–206. doi: 10.1159/000093060.
    1. Brismar K, Mogensen L, Wetterberg L. Depressed melatonin secretion in patients with nightmares due to beta-adrenoceptor blocking drugs. Acta Med Scand. 1987;221:155–158. doi: 10.1111/j.0954-6820.1987.tb01260.x.
    1. Demitrack MA, Lewy AJ, Reus VI. Pineal-adrenal interactions: the effect of acute pharmacological blockade of nocturnal melatonin secretion. Psychiatry Res. 1990;32:183–189. doi: 10.1016/0165-1781(90)90085-J.
    1. Dimsdale JE, Norman D, DeJardin D, Wallace MS. The effect of opioids on sleep architecture. J Clin Sleep Med. 2007;3:33–36.
    1. Matos G, Tufik S, Scorza FA, Cavalheiro EA, Andersen ML. Sleep and epilepsy: exploring an intriguing relationship with a translational approach. Epilepsy Behav. 2013;26:405–409. doi: 10.1016/j.yebeh.2012.12.003.
    1. Stiasny-Kolster K, Möller JC, Heinzel-Gutenbrunner M, Baum E, Ries V, Oertel WH. Validation of the restless legs syndrome screening questionnaire (RLSSQ) Somnologie Schlafforschung Schlafmed. 2009;13:37–42. doi: 10.1007/s11818-009-0402-z.
    1. Bogan RK. Effects of restless legs syndrome (RLS) on sleep. Neuropsychiatr Dis Treat. 2006;2:513–519. doi: 10.2147/nedt.2006.2.4.513.
    1. Chung F, Liao P, Elsaid H, Islam S, Shapiro CM, Sun Y. Oxygen desaturation index from nocturnal oximetry: a sensitive and specific tool to detect sleep-disordered breathing in surgical patients. Anesth Analg. 2012;114:993–1000. doi: 10.1213/ANE.0b013e318248f4f5.
    1. Hang L-W, Wang H-L, Chen J-H, Hsu J-C, Lin H-H, Chung W-S, et al. Validation of overnight oximetry to diagnose patients with moderate to severe obstructive sleep apnea. BMC Pulm Med. 2015;15. 10.1186/s12890-015-0017-z.
    1. Fabius Timon M., Benistant Jeffrey R., Bekkedam Lindsey, van der Palen Job, de Jongh Frans H. C., Eijsvogel Michiel M. M. Validation of the oxygen desaturation index in the diagnostic workup of obstructive sleep apnea. Sleep and Breathing. 2018;23(1):57–63. doi: 10.1007/s11325-018-1654-2.
    1. Morin CM. Measuring outcomes in randomized clinical trials of insomnia treatments. Sleep Med Rev. 2003;7:263–279. doi: 10.1053/smrv.2002.0274.
    1. Baglioni C, Nanovska S, Regen W, Spiegelhalder K, Feige B, Nissen C, et al. Sleep and mental disorders: A meta-analysis of polysomnographic research. Psychol Bull. 2016;142:969–990. doi: 10.1037/bul0000053.
    1. Palagini L, Baglioni C, Ciapparelli A, Gemignani A, Riemann D. REM sleep dysregulation in depression: State of the art. Sleep Med Rev. 2013;17:377–390. doi: 10.1016/j.smrv.2012.11.001.
    1. Kaplan KA, Hirshman J, Hernandez B, Stefanick ML, Hoffman AR, Redline S, et al. When a gold standard isn’t so golden: Lack of prediction of subjective sleep quality from sleep polysomnography. Biol Psychol. 2017;123:37–46. doi: 10.1016/j.biopsycho.2016.11.010.
    1. Herbert Vanessa, Pratt Daniel, Emsley Richard, Kyle Simon. Predictors of Nightly Subjective-Objective Sleep Discrepancy in Poor Sleepers over a Seven-Day Period. Brain Sciences. 2017;7(12):29. doi: 10.3390/brainsci7030029.
    1. Cheung JMY, Bartlett DJ, Armour CL, Saini B. Treating Insomnia: a review of patient perceptions toward treatment. Behav Sleep Med. 2016;14:235–266. doi: 10.1080/15402002.2014.981818.
    1. Sirdifield C, Chipchase SY, Owen S, Siriwardena AN. A systematic review and meta-synthesis of patients’ experiences and perceptions of seeking and using benzodiazepines and Z-drugs: towards safer prescribing. The Patient. 2017;10:1–15. doi: 10.1007/s40271-016-0182-z.
    1. Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017;13:307–349. doi: 10.5664/jcsm.6470.
    1. Bentley DJ, Newell J, Bishop D. Incremental exercise test design and analysis. Sports Med. 2007;37:575–586. doi: 10.2165/00007256-200737070-00002.
    1. Bonaventura JM, Sharpe K, Knight E, Fuller KL, Tanner RK, Gore CJ. Reliability and accuracy of six hand-held blood lactate analysers. J Sports Sci Med. 2015;14:203–214.
    1. Caminal P, Sola F, Gomis P, Guasch E, Perera A, Soriano N, et al. Validity of the Polar V800 monitor for measuring heart rate variability in mountain running route conditions. Eur J Appl Physiol. 2018;118:669–677. doi: 10.1007/s00421-018-3808-0.
    1. Yamamoto Y, Hughson RL, Peterson JC. Autonomic control of heart rate during exercise studied by heart rate variability spectral analysis. J Appl Physiol. 1991;71:1136–1142. doi: 10.1152/jappl.1991.71.3.1136.
    1. Borg G. Anstrengungsempfinden und körperliche Aktivität. Dtsch Ärztebl. 2004;101:A1016–A1021.
    1. Dickhuth H.-H., Huonker M., Münzel T., Drexler H., Berg A., Keul J. Advances in Ergometry. Berlin, Heidelberg: Springer Berlin Heidelberg; 1991. Individual Anaerobic Threshold for Evaluation of Competitive Athletes and Patients with Left Ventricular Dysfunction; pp. 173–179.
    1. Obbarius A, van Maasakkers L, Baer L, Clark DM, Crocker AG, de Beurs E, et al. Standardization of health outcomes assessment for depression and anxiety: recommendations from the ICHOM Depression and Anxiety Working Group. Qual Life Res. 2017;26:3211–3225. doi: 10.1007/s11136-017-1659-5.
    1. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–613. doi: 10.1046/j.1525-1497.2001.016009606.x.
    1. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x.
    1. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52:69–77. doi: 10.1016/S0022-3999(01)00296-3.
    1. Brennan C, Worrall-Davies A, McMillan D, Gilbody S, House A. The Hospital Anxiety and Depression Scale: a diagnostic meta-analysis of case-finding ability. J Psychosom Res. 2010;69:371–378. doi: 10.1016/j.jpsychores.2010.04.006.
    1. Norton S, Cosco T, Doyle F, Done J, Sacker A. The Hospital Anxiety and Depression Scale: A meta confirmatory factor analysis. J Psychosom Res. 2013;74:74–81. doi: 10.1016/j.jpsychores.2012.10.010.
    1. Herrmann C, Buss U, HADS-D SRP. Hospital Anxiety and Depression Scale - Deutsche Version (HADS-D - Hospital Anxiety and Depression Scale - German version) Bern: Huber; 2011.
    1. Klein EM, Brähler E, Dreier M, Reinecke L, Müller KW, Schmutzer G, et al. The German version of the Perceived Stress Scale – psychometric characteristics in a representative German community sample. BMC Psychiatry. 2016;16. 10.1186/s12888-016-0875-9.
    1. Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med. 2002;64:258–266. doi: 10.1097/00006842-200203000-00008.
    1. Linn BS, Linn M, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc. 1968;16:622–626. doi: 10.1111/j.1532-5415.1968.tb02103.x.
    1. Backhaus J, Riemann D. Schlafstörungen bewältigen [Coping with sleep disorders]. Weinheim: Beltz Psychology Verlags Union; 1996.
    1. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213. doi: 10.1016/0165-1781(89)90047-4.
    1. Chiu H-Y, Chang L-Y, Hsieh Y-J, Tsai P-S. A meta-analysis of diagnostic accuracy of three screening tools for insomnia. J Psychosom Res. 2016;87:85–92. doi: 10.1016/j.jpsychores.2016.06.010.
    1. Drake C, Richardson G, Roehrs T, Scofield H, Roth T. Vulnerability to stress-related sleep disturbance and hyperarousal. Sleep. 2004;27:285–291. doi: 10.1093/sleep/27.2.285.
    1. Kalmbach DA, Pillai V, Arnedt JT, Drake CL. Identifying at-risk individuals for insomnia using the Ford Insomnia Response to Stress Test. Sleep. 2016;39:449–456. doi: 10.5665/sleep.5462.
    1. Dieck Arne, Helbig Susanne, Drake Christopher L., Backhaus Jutta. Validation of the German version of the Ford Insomnia Response to Stress Test. Journal of Sleep Research. 2017;27(3):e12621. doi: 10.1111/jsr.12621.
    1. Harvey AG, Tang NKY, Browning L. Cognitive approaches to insomnia. Clin Psychol Rev. 2005;25:593–611. doi: 10.1016/j.cpr.2005.04.005.
    1. Lang Christin, Brand Serge, Holsboer-Trachsler Edith, Pühse Uwe, Colledge Flora, Gerber Markus. Validation of the German version of the short form of the dysfunctional beliefs and attitudes about sleep scale (DBAS-16) Neurological Sciences. 2017;38(6):1047–1058. doi: 10.1007/s10072-017-2921-x.
    1. Ishak WW, Bagot K, Thomas S, Magakian N, Bedwani D, Larson D, et al. Quality of life in patients suffering from insomnia. Innov Clin Neurosci. 2012;9:13–26.
    1. Hein M, Lanquart J-P, Loas G, Hubain P, Linkowski P. Prevalence and risk factors of excessive daytime sleepiness in insomnia sufferers: A study with 1311 individuals. J Psychosom Res. 2017;103:63–69. doi: 10.1016/j.jpsychores.2017.10.004.
    1. Slater G, Steier J. Excessive daytime sleepiness in sleep disorders. J Thorac Dis. 2012;4:608–616.
    1. Bloch KE, Schoch OD, Zhang JN, Russi EW. German version of the Epworth Sleepiness Scale. Respir Int Rev Thorac Dis. 1999;66:440–447.
    1. Chan JWY, Lam SP, Li SX, Yu MWM, Chan NY, Zhang J, et al. Eveningness and insomnia: independent risk factors of nonremission in major depressive disorder. Sleep. 2014;37:911–917. doi: 10.5665/sleep.3658.
    1. Horne JA, Ostberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol. 1976;4:97–110.
    1. Kantermann T, Sung H, Burgess HJ. Comparing the Morningness-Eveningness Questionnaire and Munich ChronoType Questionnaire to the dim light melatonin onset. J Biol Rhythm. 2015;30:449–453. doi: 10.1177/0748730415597520.
    1. Griefahn B, Künemund C, Bröde P, Mehnert P. Zur Validität der deutschen Übersetzung des Morningness-Eveningness-Questionnaires von Horne und Östberg. Somnologie. 2001;5:71–80. doi: 10.1046/j.1439-054X.2001.01149.x.
    1. Water ATMVD, Holmes A, Hurley DA. Objective measurements of sleep for non-laboratory settings as alternatives to polysomnography – a systematic review. J Sleep Res. 2011;20:183–200. doi: 10.1111/j.1365-2869.2009.00814.x.
    1. Newell J, Mairesse O, Verbanck P, Neu D. Is a one-night stay in the lab really enough to conclude? First-night effect and night-to-night variability in polysomnographic recordings among different clinical population samples. Psychiatry Res. 2012;200:795–801. doi: 10.1016/j.psychres.2012.07.045.
    1. Song S, Geng Z, Zhai S, Xu J, Hou G, Zhang X. Changes of sleep adaptation in hospitalized patients with depression. Cell Biochem Biophys. 2013;66:347–350. doi: 10.1007/s12013-012-9454-y.
    1. Mendels J, Hawkins DR. Sleep laboratory adaptation in normal subjects and depressed patients (“first night effect”) Electroencephalogr Clin Neurophysiol. 1967;22:556–558. doi: 10.1016/0013-4694(67)90063-6.
    1. Toussaint M, Luthringer R, Schaltenbrand N, Carelli G, Lainey E, Jacqmin A, et al. First-night effect in normal subjects and psychiatric inpatients. Sleep. 1995;18:463–469. doi: 10.1093/sleep/18.6.463.
    1. Bland JM, Altman DG. Best (but oft forgotten) practices: testing for treatment effects in randomized trials by separate analyses of changes from baseline in each group is a misleading approach. Am J Clin Nutr. 2015;102:991–994. doi: 10.3945/ajcn.115.119768.
    1. Vickers AJ, Altman DG. Analysing controlled trials with baseline and follow up measurements. BMJ. 2001;323:1123–1124. doi: 10.1136/bmj.323.7321.1123.
    1. Berry RB, Brooks R, Gamaldo CE, Harding SM, Marcus CL, Vaughn BV. The AASM manual for the scoring of sleep and associated events. Rules Terminol Tech Specif Darien Ill Am Acad Sleep Med. 2012.
    1. Fietze I, Penzel T, Partinen M, Sauter J, Küchler G, Suvoro A, et al. Actigraphy combined with EEG compared to polysomnography in sleep apnea patients. Physiol Meas. 2015;36:385–396. doi: 10.1088/0967-3334/36/3/385.
    1. Brand Serge, Kalak Nadeem, Gerber Markus, Kirov Roumen, Pühse Uwe, Holsboer-Trachsler Edith. High self-perceived exercise exertion before bedtime is associated with greater objectively assessed sleep efficiency. Sleep Medicine. 2014;15(9):1031–1036. doi: 10.1016/j.sleep.2014.05.016.
    1. Cohen BE, Edmondson D, Kronish IM. State of the art review: Depression, stress, anxiety, and cardiovascular disease. Am J Hypertens. 2015;28:1295–1302. doi: 10.1093/ajh/hpv047.
    1. Penninx BWJH. Depression and cardiovascular disease: Epidemiological evidence on their linking mechanisms. Neurosci Biobehav Rev. 2017;74:277–286. doi: 10.1016/j.neubiorev.2016.07.003.
    1. Javaheri Sogol, Redline Susan. Insomnia and Risk of Cardiovascular Disease. Chest. 2017;152(2):435–444. doi: 10.1016/j.chest.2017.01.026.
    1. Yano Y, Kario K. Nocturnal blood pressure and cardiovascular disease: a review of recent advances. Hypertens Res. 2012;35:695–701. doi: 10.1038/hr.2012.26.
    1. Task Force of the European Society of Cardiology the North American Society of Pacing Heart Rate Variability Standards of Measurement, Physiological Interpretation, and Clinical Use. Circulation. 1996;93:1043–1065. doi: 10.1161/01.CIR.93.5.1043.
    1. Lerma C, Martinez A, Ruiz N, Vargas A, Infante O, Martinez-Lavin M. Nocturnal heart rate variability parameters as potential fibromyalgia biomarker: correlation with symptoms severity. Arthritis Res Ther. 2011;13:R185. doi: 10.1186/ar3513.
    1. Hynynen E, Vesterinen V, Rusko H, Nummela A. Effects of moderate and heavy endurance exercise on nocturnal HRV. Int J Sports Med. 2010;31:428–432. doi: 10.1055/s-0030-1249625.
    1. Boudreau P, Yeh W-H, Dumont GA, Boivin DB. Circadian variation of heart rate variability across sleep stages. Sleep. 2013;36:1919–1928. doi: 10.5665/sleep.3230.
    1. Johann AF, Hertenstein E, Kyle SD, Baglioni C, Feige B, Nissen C, et al. Insomnia with objective short sleep duration is associated with longer duration of insomnia in the Freiburg Insomnia Cohort compared to insomnia with normal sleep duration, but not with hypertension. PLoS One. 2017;12:e0180339. doi: 10.1371/journal.pone.0180339.
    1. Vgontzas AN, Fernandez-Mendoza J, Liao D, Bixler EO. Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder. Sleep Med Rev. 2013;17:241–254. doi: 10.1016/j.smrv.2012.09.005.
    1. Tobaldini E, Nobili L, Strada S, Casali KR, Braghiroli A, Montano N. Heart rate variability in normal and pathological sleep. Front Physiol. 2013;4:294. doi: 10.3389/fphys.2013.00294.
    1. Burr RL. Interpretation of normalized spectral heart rate variability indices in sleep research: a critical review. Sleep. 2007;30:913–919. doi: 10.1093/sleep/30.7.913.
    1. Laborde S, Mosley E, Thayer JF. Heart rate variability and cardiac vagal tone in psychophysiological research – recommendations for experiment planning, data analysis, and data reporting. Front Psychol. 2017;8. 10.3389/fpsyg.2017.00213.
    1. Heathers JAJ. Everything Hertz: methodological issues in short-term frequency-domain HRV. Front Physiol. 2014;5:177. doi: 10.3389/fphys.2014.00177.
    1. Quintana DS, Alvares GA. Heathers JA. Guidelines for reporting articles on psychiatry and heart rate variability (GRAPH): recommendations to advance research communication. Transl Psychiatry. 2016;6:e803. doi: 10.1038/tp.2016.73.
    1. Lomb NR. Least-squares frequency analysis of unequally spaced data. Astrophys Space Sci. 1976;39:447–462. doi: 10.1007/BF00648343.
    1. Scargle JD. Studies in astronomical time series analysis. II-Statistical aspects of spectral analysis of unevenly spaced data. Astrophys J. 1982;263:835–853. doi: 10.1086/160554.
    1. Laguna P, Moody GB, Mark RG. Power spectral density of unevenly sampled data by least-square analysis: performance and application to heart rate signals. IEEE Trans Biomed Eng. 1998;45:698–715. doi: 10.1109/10.678605.
    1. Saini BS, Singh D, Uddin M, Kumar V. Improved power spectrum estimation for RR-interval time series. World Acad Sci Eng Technol. 2008;46:44–48.
    1. Singh D, Vinod K, Saxena SC, Deepak KK. Effects of RR segment duration on HRV spectrum estimation. Physiol Meas. 2004;25:721. doi: 10.1088/0967-3334/25/3/012.
    1. Burr RL, Cowan MJ. Autoregressive spectral models of heart rate variability. Practical issues. J Electrocardiol. 1992;25(Suppl):224–233. doi: 10.1016/0022-0736(92)90108-C.
    1. Moody GB. Spectral analysis of heart rate without resampling. In: Proceedings of Computers in Cardiology Conference. Washington, D.C.: IEEE; 1993. p. 715–8.
    1. Chang KL, Monahan KJ, Griffin MP, Lake D, Moorman JR. Comparison and clinical application of frequency domain methods in analysis of neonatal heart rate time series. Ann Biomed Eng. 2001;29:764–774. doi: 10.1114/1.1397791.
    1. Clifford GD, Tarassenko L. Quantifying errors in spectral estimates of HRV due to beat replacement and resampling. IEEE Trans Biomed Eng. 2005;52:630–638. doi: 10.1109/TBME.2005.844028.
    1. Mukherjee S, Yadav R, Yung I, Zajdel DP, Oken BS. Sensitivity to mental effort and test-retest reliability of heart rate variability measures in healthy seniors. Clin Neurophysiol. 2011;122:2059–2066.
    1. Delane A, Bohorquez J, Gupta S, Schiavenato M. Lomb algorithm versus fast Fourier transform in heart rate variability analyses of pain in premature infants. Conf Proc IEEE Eng Med Biol Soc. 2016;2016:944–947.
    1. Thong T, Yung IO, P Zajdel DP, Ellingson RM, McNames J, Aboy M, et al. Heart rate variability analysis of effect of nicotine using periodograms. Conf Proc IEEE Eng Med Biol Soc. 2004;1:294–297.
    1. Van Dongen HP, Olofsen E, VanHartevelt JH, Kruyt EW. Searching for biological rhythms: peak detection in the periodogram of unequally spaced data. J Biol Rhythm. 1999;14:617–620. doi: 10.1177/074873099129000984.
    1. Tarvainen MP, Niskanen J-P, Lipponen JA, Ranta-aho PO, Karjalainen PA. Kubios HRV – Heart rate variability analysis software. Comput Methods Prog Biomed. 2014;113:210–220. doi: 10.1016/j.cmpb.2013.07.024.
    1. Pan J, Tompkins WJ. A real-time QRS detection algorithm. IEEE Trans Biomed Eng. 1985;32:230–236. doi: 10.1109/TBME.1985.325532.
    1. Tarvainen M, Lipponen J, Niskanen J-P, Ranta-aho P. Kubios HRV version 3.1 User’s Guide. 2018.
    1. Rincon Soler AI, Silva LEV, Fazan R, Murta LO. The impact of artifact correction methods of RR series on heart rate variability parameters. J Appl Physiol. 2017;124:646–652. doi: 10.1152/japplphysiol.00927.2016.
    1. Tarvainen MP, Ranta-aho PO, Karjalainen PA. An advanced detrending method with application to HRV analysis. IEEE Trans Biomed Eng. 2002;49:172–175. doi: 10.1109/10.979357.
    1. Bilo G, Zorzi C, Ochoa Munera JE, Torlasco C, Giuli V, Parati G. Validation of the Somnotouch-NIBP noninvasive continuous blood pressure monitor according to the European Society of Hypertension International Protocol revision 2010. Blood Press Monit. 2015;20:291–294. doi: 10.1097/MBP.0000000000000124.
    1. O’Brien E, Atkins N, Stergiou G, Karpettas N, Parati G, Asmar R, et al. European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults. Blood Press Monit. 2010;15:23–38. doi: 10.1097/MBP.0b013e3283360e98.
    1. Verdecchia P, Angeli F, Borgioni C, Gattobigio R, Reboldi G. Ambulatory blood pressure and cardiovascular outcome in relation to perceived sleep deprivation. Hypertension. 2007;49:777–783. doi: 10.1161/01.HYP.0000258215.26755.20.
    1. Séi H. Blood pressure surges in REM sleep: A mini review. Pathophysiology. 2012;19:233–241. doi: 10.1016/j.pathophys.2012.04.006.
    1. Palagini L, Moretto U, Dell’Osso L, Carney C. Sleep-related cognitive processes, arousal, and emotion dysregulation in insomnia disorder: the role of insomnia-specific rumination. Sleep Med. 2017;30:97–104. doi: 10.1016/j.sleep.2016.11.004.
    1. Karlson CW, Stevens NR, Olson CA, Hamilton NA. Depression, fatigue, and pre-sleep arousal: a mediation model. J Coll Stud Psychother. 2010;24:307–327. doi: 10.1080/87568225.2010.509259.
    1. Gieselmann A, de Jong-Meyer R, Pietrowsky R. Kognitive und körperliche Erregung in der Phase vor dem Einschlafen. Z Für Klin Psychol Psychother. 2012;41:73–80. doi: 10.1026/1616-3443/a000134.
    1. Riemann D, Baum E, Cohrs S, Crönlein T, Hajak G, Hertenstein E, et al. S3-Leitlinie Nicht erholsamer Schlaf/Schlafstörungen. Somnologie. 2017;21:2–44. doi: 10.1007/s11818-016-0097-x.
    1. Görtelmeyer R, Schlaffragebogen A und B. SF-A/R und SF-B/R: Hogrefe; 2011.
    1. Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC. Quantification of sleepiness: a new approach. Psychophysiology. 1973;10:431–436. doi: 10.1111/j.1469-8986.1973.tb00801.x.
    1. MacLean AW, Fekken GC, Saskin P, Knowles JB. Psychometric evaluation of the Stanford Sleepiness Scale. J Sleep Res. 1992;1:35–39. doi: 10.1111/j.1365-2869.1992.tb00006.x.
    1. Morgenthaler T, Kramer M, Alessi C, Friedman L, Boehlecke B, Brown T, et al. Practice parameters for the psychological and behavioral treatment of insomnia: an update. An american academy of sleep medicine report. Sleep. 2006;29:1415–1419. doi: 10.1093/sleep/29.9.1203.
    1. Horvath P. Treatment expectancy as a function of the amount of information presented in therapeutic rationales. J Clin Psychol. 1990;46:636–642. doi: 10.1002/1097-4679(199009)46:5<636::AID-JCLP2270460516>;2-U.
    1. Rutherford BR, Wager TD, Roose SP. Expectancy and the treatment of depression: a review of experimental methodology and effects on patient outcome. Curr Psychiatr Rev. 2010;6:1–10. doi: 10.2174/157340010790596571.
    1. Devilly GJ, Borkovec TD. Psychometric properties of the credibility/expectancy questionnaire. J Behav Ther Exp Psychiatry. 2000;31:73–86. doi: 10.1016/S0005-7916(00)00012-4.
    1. Williams AD, Blackwell SE, Mackenzie A, Holmes EA, Andrews G. Combining imagination and reason in the treatment of depression: a randomized controlled trial of internet-based cognitive-bias modification and internet-CBT for depression. J Consult Clin Psychol. 2013;81:793. doi: 10.1037/a0033247.
    1. O’Callaghan CA. OxMaR: open source free software for online minimization and randomization for clinical trials. PLoS One. 2014;9:e110761. doi: 10.1371/journal.pone.0110761.
    1. Haskell WL, Lee I-M, Pate RR, Powell KE, Blair SN, Franklin BA, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation. 2007;116:1081–93.
    1. Abele-Brehm A, Brehm W. Zur Konzeptualisierung und Messung von Befindlichkeit: Die Entwicklung der “Befindlichkeitsskalen” (BFS) [The conceptualization and measurement of mood: The development of the “Mood Survey.”] Diagnostica. 1986;32:209–228.
    1. Kellmann M, Golenia M. Skalen zur Erfassung der aktuellen Befindlichkeit im Sport. Dtsch Z Sportmed. 2003;54:329–330.
    1. Höchsmann C., Knaier R., Eymann J., Hintermann J., Infanger D., Schmidt-Trucksäss A. Validity of activity trackers, smartphones, and phone applications to measure steps in various walking conditions. Scandinavian Journal of Medicine & Science in Sports. 2018;28(7):1818–1827. doi: 10.1111/sms.13074.
    1. Castor Electronic Data Capture. Amsterdam: Ciwit BV; 2018.
    1. Kahan BC, Morris TP. Reporting and analysis of trials using stratified randomisation in leading medical journals: review and reanalysis. BMJ. 2012;345:e5840. doi: 10.1136/bmj.e5840.
    1. Borm GF, Fransen J, Lemmens WAJG. A simple sample size formula for analysis of covariance in randomized clinical trials. J Clin Epidemiol. 2007;60:1234–1238. doi: 10.1016/j.jclinepi.2007.02.006.
    1. Youngstedt SD. Ceiling and floor effects in sleep research. Sleep Med Rev. 2003;7:351–365. doi: 10.1053/smrv.2001.0239.
    1. Rubio-Arias JÁ, Marín-Cascales E, Ramos-Campo DJ, Hernandez AV, Pérez-López FR. Effect of exercise on sleep quality and insomnia in middle-aged women: A systematic review and meta-analysis of randomized controlled trials. Maturitas. 2017;100:49–56. doi: 10.1016/j.maturitas.2017.04.003.
    1. Follmann D, Elliott P, Suh I, Cutler J. Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol. 1992;45:769–773. doi: 10.1016/0895-4356(92)90054-Q.
    1. Rosenthal R. Meta-analytic procedures for social research. Beverly Hills: CA: Sage; 1991.
    1. Stubbs B, Vancampfort D, Rosenbaum S, Ward PB, Richards J, Soundy A, et al. Dropout from exercise randomized controlled trials among people with depression: A meta-analysis and meta regression. J Affect Disord. 2016;190:457–466. doi: 10.1016/j.jad.2015.10.019.
    1. Su Y-S, Gelman A, Hill J, Yajima M. Multiple imputation with diagnostics (mi) in R: Opening windows into the black box. J Stat Softw. 2011;45:1–31. doi: 10.18637/jss.v045.i02.
    1. Benjamini Yoav, Hochberg Yosef. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society: Series B (Methodological) 1995;57(1):289–300.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi